Blau Farmaceutica (BSP:BLAU3) EBIT per Share : R$1.74 (TTM As of Sep. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Blau Farmaceutica EBIT per Share?

Blau Farmaceutica's EBIT per Share for the three months ended in Sep. 2024 was R$0.63. Its EBIT per Share for the trailing twelve months (TTM) ended in Sep. 2024 was R$1.74.

During the past 12 months, the average EBIT per Share Growth Rate of Blau Farmaceutica was -31.40% per year. During the past 3 years, the average EBIT per Share Growth Rate was -5.60% per year. During the past 5 years, the average EBIT per Share Growth Rate was 10.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.

The historical rank and industry rank for Blau Farmaceutica's EBIT per Share or its related term are showing as below:

BSP:BLAU3' s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: -5.6 Med: 29.7 Max: 65.8
Current: -5.6

During the past 8 years, the highest 3-Year average EBIT per Share Growth Rate of Blau Farmaceutica was 65.80% per year. The lowest was -5.60% per year. And the median was 29.70% per year.

BSP:BLAU3's 3-Year EBIT Growth Rate is ranked worse than
70.18% of 825 companies
in the Drug Manufacturers industry
Industry Median: 6.6 vs BSP:BLAU3: -5.60

Blau Farmaceutica's EBIT for the three months ended in Sep. 2024 was R$114 Mil.

Blau Farmaceutica EBIT per Share Historical Data

The historical data trend for Blau Farmaceutica's EBIT per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Blau Farmaceutica EBIT per Share Chart

Blau Farmaceutica Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

EBIT per Share

Get a 7-Day Free Trial

1.72

2.11

2.84

2.79

2.04

Blau Farmaceutica Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
EBIT per Share	Get a 7-Day Free Trial															0.92	0.30	0.35	0.47	0.63

Blau Farmaceutica EBIT per Share Calculation

EBIT per Share is the amount of Earnings Before Interest and Taxes (EBIT) per outstanding share of the company's stock.

Earnings Before Interest and Taxes (EBIT) is what the company earns before it expenses interest and taxes.

Blau Farmaceutica's EBIT per Share for the fiscal year that ended in Dec. 2023 is calculated as

	EBIT per Share		(A: Dec. 2023 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	366.343	/	179.394
=	2.04

Blau Farmaceutica's EBIT per Share for the quarter that ended in Sep. 2024 is calculated as

	EBIT per Share		(Q: Sep. 2024 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	113.708	/	180.892
=	0.63

EBIT per Share for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was R$1.74

Blau Farmaceutica (BSP:BLAU3) EBIT per Share Explanation

EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.

Blau Farmaceutica EBIT per Share Related Terms

Thank you for viewing the detailed overview of Blau Farmaceutica's EBIT per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Blau Farmaceutica Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Blau Farmaceutica SA (BSP:BLAU3) » Definitions » EBIT per Share

Comparable Companies

Traded in Other Exchanges

N/A

Address

Rodovia Raposo Tavares, No. 2833, Km 30.5, Barro Branco, Cotia, SP, BRA, 06705-030

Website

https://www.blau.com

Blau Farmaceutica SA is engaged in the manufacturing, development and commercialization of complex private-label drugs for the institutional segment. The Company's business activities cover institutional and retail segments, and are divided into four units: 1) Biologicals are a heterogeneous class of products that can be produced using raw materials from biological materials and biotechnological procedures. 2) Oncology line is made up of oral and injectable drugs intended for treating cancer, which encompasses a number of therapeutic classes. 3) Specialties line is made up of products that are used in the hospital's daily routine, in the specialized treatments for infectious diseases and special treatments. 4) Others consist of prescription and non-prescription over-the-counter drugs.

Blau Farmaceutica Headlines

No Headlines